Total Payments
$18,891
2024 Payments
$200.00
Companies
11
Transactions
40
Medicare Patients
1,007
Medicare Billing
$177,068
Payment Breakdown by Category
Other$15,250 (80.7%)
Food & Beverage$2,237 (11.8%)
Travel$1,174 (6.2%)
Consulting$200.00 (1.1%)
Education$29.95 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,250 | 7 | 80.7% |
| Food and Beverage | $2,237 | 26 | 11.8% |
| Travel and Lodging | $1,174 | 5 | 6.2% |
| Consulting Fee | $200.00 | 1 | 1.1% |
| Education | $29.95 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $17,276 | 25 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $415.83 | 3 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $399.52 | 4 | $0 (2021) |
| Allergan Inc. | $124.43 | 1 | $0 (2017) |
| IDORSIA PHARMACEUTICALS US INC | $121.87 | 1 | $0 (2023) |
| ITI, Inc. | $119.88 | 1 | $0 (2023) |
| Grifols USA, LLC | $119.55 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $96.94 | 1 | $0 (2020) |
| ABBVIE INC. | $96.60 | 1 | $0 (2023) |
| Alkermes, Inc. | $91.12 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $200.00 | 1 | Janssen Scientific Affairs, LLC ($200.00) |
| 2023 | $17,753 | 29 | Janssen Pharmaceuticals, Inc ($17,199) |
| 2022 | $76.52 | 1 | Janssen Pharmaceuticals, Inc ($76.52) |
| 2021 | $101.91 | 1 | Neurocrine Biosciences, Inc. ($101.91) |
| 2020 | $96.94 | 1 | Otsuka America Pharmaceutical, Inc. ($96.94) |
| 2019 | $178.53 | 2 | Neurocrine Biosciences, Inc. ($178.53) |
| 2018 | $91.12 | 1 | Alkermes, Inc. ($91.12) |
| 2017 | $393.01 | 4 | Allergan Inc. ($124.43) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/07/2024 | Janssen Scientific Affairs, LLC | SPRAVATO (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Neuroscience | ||||||
| 11/20/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Neuroscience | ||||||
| 11/08/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| Category: Neuroscience | ||||||
| 11/07/2023 | Janssen Scientific Affairs, LLC | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $93.66 | General |
| Category: Neuroscience | ||||||
| 10/24/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Neuroscience | ||||||
| 10/24/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Neuroscience | ||||||
| 10/11/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $112.97 | General |
| Category: Neuroscience | ||||||
| 09/01/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $89.62 | General |
| Category: Neuroscience | ||||||
| 08/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $96.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| Category: Neuroscience | ||||||
| 07/21/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $121.87 | General |
| Category: INSOMNIA | ||||||
| 05/17/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Neuroscience | ||||||
| 05/17/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $67.49 | General |
| Category: Neuroscience | ||||||
| 05/16/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $119.88 | General |
| Category: PSYCHIATRY | ||||||
| 05/11/2023 | Janssen Scientific Affairs, LLC | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $122.17 | General |
| Category: Neuroscience | ||||||
| 04/07/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $142.55 | General |
| Category: Neuroscience | ||||||
| 04/06/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Neuroscience | ||||||
| 03/04/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| Category: Neuroscience | ||||||
| 03/04/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $580.80 | General |
| Category: Neuroscience | ||||||
| 03/04/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $355.93 | General |
| Category: Neuroscience | ||||||
| 03/04/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $56.70 | General |
| Category: Neuroscience | ||||||
| 03/04/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $51.95 | General |
| Category: Neuroscience | ||||||
| 03/04/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $37.49 | General |
| Category: Neuroscience | ||||||
| 03/04/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Neuroscience | ||||||
| 03/04/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 219 | 542 | $128,454 | $47,190 |
| 2022 | 4 | 230 | 503 | $117,835 | $44,322 |
| 2021 | 5 | 251 | 544 | $117,040 | $46,296 |
| 2020 | 8 | 307 | 623 | $106,517 | $39,260 |
Total Patients
1,007
Total Services
2,212
Medicare Billing
$177,068
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 316 | $81,844 | $30,863 | 37.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 34 | 108 | $14,256 | $5,676 | 39.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 40 | 40 | $17,720 | $5,363 | 30.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 60 | $10,080 | $3,889 | 38.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 12 | 18 | $4,554 | $1,400 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 238 | $55,930 | $22,545 | 40.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 56 | 58 | $25,694 | $8,255 | 32.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 100 | $16,800 | $5,970 | 35.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 27 | 90 | $11,880 | $5,079 | 42.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 17 | 17 | $7,531 | $2,471 | 32.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 210 | $47,040 | $21,169 | 45.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 52 | 53 | $23,479 | $7,785 | 33.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 123 | $20,664 | $7,327 | 35.5% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 45 | 127 | $16,764 | $6,609 | 39.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 15 | 15 | $6,645 | $2,454 | 36.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 16 | $2,448 | $952.48 | 38.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 52 | 124 | $20,832 | $7,479 | 35.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 49 | 141 | $18,612 | $7,256 | 39.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 82 | $17,466 | $6,304 | 36.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 113 | $16,498 | $5,903 | 35.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 40 | 69 | $7,038 | $4,174 | 59.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 33 | 33 | $14,619 | $3,654 | 25.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 15 | 23 | $3,358 | $2,135 | 63.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 15 | 15 | $6,645 | $1,494 | 22.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 16 | 23 | $1,449 | $862.06 | 59.5% |
About Dr. Matthew Filippo, DO
Dr. Matthew Filippo, DO is a Psychiatry healthcare provider based in Park Ridge, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2015. The National Provider Identifier (NPI) number assigned to this provider is 1780078337.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Filippo, DO has received a total of $18,891 in payments from pharmaceutical and medical device companies, with $200.00 received in 2024. These payments were reported across 40 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,250).
As a Medicare-enrolled provider, Filippo has provided services to 1,007 Medicare beneficiaries, totaling 2,212 services with total Medicare billing of $177,068. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Park Ridge, IL
- Active Since 03/21/2015
- Last Updated 01/20/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1780078337
Products in Payments
- SPRAVATO (Drug) $17,691
- INGREZZA (Drug) $399.52
- VRAYLAR (Drug) $221.03
- QUVIVIQ (Drug) $121.87
- CAPLYTA (Drug) $119.88
- HyperRAB SD (Biological) $119.55
- REXULTI (Drug) $96.94
- Aristada 441 mg (Drug) $91.12
- BELSOMRA (Drug) $29.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Park Ridge
Laura Van Dusen, Md, MD
Psychiatry — Payments: $6,122
Psychiatry $6,122
Dr. Warren Kammerer, Md, MD
Psychiatry — Payments: $5,834
Psychiatry $5,834
Joanna Poniatowicz, Md, MD
Psychiatry — Payments: $2,183
Psychiatry $2,183
Lara Segalite, Md, MD
Psychiatry — Payments: $2,140
Psychiatry $2,140
Justin Lam, D.o, D.O
Psychiatry — Payments: $1,709
Psychiatry $1,709
Andrew Pundy, Md, MD
Psychiatry — Payments: $1,690
Psychiatry $1,690